These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failure. Wu AH; Ghali JK; Neuberg GW; O'Connor CM; Carson PE; Levy WC Am Heart J; 2010 Nov; 160(5):928-33. PubMed ID: 21095282 [TBL] [Abstract][Full Text] [Related]
8. The effects of maximal treadmill graded exercise testing on haemorheological, haemodynamic and flow cytometry platelet markers in patients with systolic or diastolic heart failure. Chung I; Goyal D; Macfadyen RJ; Lip GY Eur J Clin Invest; 2008 Mar; 38(3):150-8. PubMed ID: 18257777 [TBL] [Abstract][Full Text] [Related]
9. Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure. Tsutamoto T; Kawahara C; Nishiyama K; Yamaji M; Fujii M; Yamamoto T; Horie M Am Heart J; 2010 Jan; 159(1):63-7. PubMed ID: 20102868 [TBL] [Abstract][Full Text] [Related]
10. Prognostic usefulness of anemia and N-terminal pro-brain natriuretic peptide in outpatients with systolic heart failure. Schou M; Gustafsson F; Kistorp CN; Corell P; Kjaer A; Hildebrandt PR Am J Cardiol; 2007 Nov; 100(10):1571-6. PubMed ID: 17996522 [TBL] [Abstract][Full Text] [Related]
11. Urocortins in heart failure. Venkatasubramanian S; Newby DE; Lang NN Biochem Pharmacol; 2010 Aug; 80(3):289-96. PubMed ID: 20363214 [TBL] [Abstract][Full Text] [Related]
13. Elevation of plasmatic endothelin in patients with heart failure. Galindo-Fraga A; Arrieta O; Castillo-Martínez L; Narváez R; Oseguera-Moguel J; Orea-Tejeda A Arch Med Res; 2003; 34(5):367-72. PubMed ID: 14602502 [TBL] [Abstract][Full Text] [Related]
14. Effect of urocortin 1 infusion in humans with stable congestive cardiac failure. Davis ME; Pemberton CJ; Yandle TG; Lainchbury JG; Rademaker MT; Nicholls MG; Frampton CM; Richards AM Clin Sci (Lond); 2005 Oct; 109(4):381-8. PubMed ID: 15882144 [TBL] [Abstract][Full Text] [Related]
15. Increased circulating big endothelin-1, endothelin-1 and atrial natriuretic peptide in infants and children with heart failure secondary to congenital heart disease. Yeh JL; Hsu JH; Dai ZK; Liou SF; Chen IJ; Wu JR Int J Cardiol; 2005 Sep; 104(1):15-20. PubMed ID: 16055212 [TBL] [Abstract][Full Text] [Related]
16. Deficiencies in circulating testosterone and dehydroepiandrosterone sulphate, and depression in men with systolic chronic heart failure. Jankowska EA; Drohomirecka A; Ponikowska B; Witkowska A; Lopuszanska M; Szklarska A; Borodulin-Nadzieja L; Banasiak W; Poole-Wilson PA; Ponikowski P Eur J Heart Fail; 2010 Sep; 12(9):966-73. PubMed ID: 20595194 [TBL] [Abstract][Full Text] [Related]
17. Endogenous urocortins reduce vascular tone and renin-aldosterone/endothelin activity in experimental heart failure. Rademaker MT; Charles CJ; Espiner EA; Frampton CM; Lainchbury JG; Richards AM Eur Heart J; 2005 Oct; 26(19):2046-54. PubMed ID: 15821006 [TBL] [Abstract][Full Text] [Related]
18. The prognostic value of big endothelin-1 in more than 2,300 patients with heart failure enrolled in the Valsartan Heart Failure Trial (Val-HeFT). Masson S; Latini R; Anand IS; Barlera S; Judd D; Salio M; Perticone F; Perini G; Tognoni G; Cohn JN; J Card Fail; 2006 Jun; 12(5):375-80. PubMed ID: 16762801 [TBL] [Abstract][Full Text] [Related]
19. Relationship between thoracic fluid content and natriuretic peptide type B in patients with systolic heart failure. Balak W; Sinkiewicz W; Gilewski W; Karasek D; Błazejewski J; Dudziak J Kardiol Pol; 2009 Nov; 67(11):1220-5. PubMed ID: 20024849 [TBL] [Abstract][Full Text] [Related]
20. Urocortins in heart failure and ischemic heart disease. Boonprasert P; Lailerd N; Chattipakorn N Int J Cardiol; 2008 Jul; 127(3):307-12. PubMed ID: 18180061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]